Navigation Links
AlphaDetail Tracking Study Enhancements: The Advantage of Integration and Speed

SAN MATEO, Calif., Oct. 20 /PRNewswire/ -- AlphaDetail, an innovator in pharmaceutical marketing research, is pleased to introduce two new features to its suite of tracking services: AlphaLink and AlphaMonitor.

AlphaLink helps clients better understand their competitive landscape by integrating secondary research with tracking study results. "One of the biggest issues facing clients today is managing through vast amounts of data, gathered from a number of different sources," says Rishi Varma, co-founder of AlphaDetail. "AlphaLink provides an integrated view of a market, enabling a more focused, holistic market understanding."

AlphaMonitor provides real-time online access with up-to-the-minute results for any of the company's tracking services - from continuous tracking to monitoring key variables in periodic tracking studies. "Pharmaceutical and biotech marketers are frequently looking for fast insights to react to market changes," reports Dave Johnson, Vice President of AlphaDetail's Professional Services team. "AlphaMonitor offers instant views and dynamic access to study results that enable marketers to quickly understand and react to feedback from the market."

To learn more about AlphaDetail's Tracking services, please contact Bob Latshaw at or (215) 259-5601, or visit us at

About AlphaDetail, Inc.:

AlphaDetail, Inc. is an innovator in primary market research and KOL Identification serving the global biopharmaceutical industry. AlphaDetail's expertise spans every continent, a wide array of therapeutic areas and every stage of the product life cycle. Our clients include the top pharmaceutical, biotech and medical device companies in the world, as well as companies of all sizes. AlphaDetail is built on one of the industry's strongest foundations that include a large team of exceptional analytical specialists, the industry's leading technology platform and a flexible approach to research that helps us to answer our client's most challenging questions.

SOURCE AlphaDetail, Inc.

SOURCE AlphaDetail, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
2. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
3. Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico
4. comScore Study Finds the Internet a Key Component in Consumer Research on Prescriptions and Health Conditions
5. Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
6. CVS Caremark Undertakes Multi-Year Study to Improve Patient Medication Adherence
7. ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities
8. DATATRAK Signs 6 Year Study with New Device Client
9. Study Suggests that NGAL Identifies Acute Kidney Injury Early in ICU Patients
10. Bundling Two Generic Low-Cost Heart Drugs Prevents Heart Attack and Stroke in Large, Diverse Population, Observational Clinical Study Shows
11. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
Post Your Comments:
(Date:6/24/2016)... June 24, 2016  Collagen Matrix, Inc., ("Collagen ... and manufacturing of collagen and mineral based medical ... that Bill Messer has joined the ... further leverage the growing portfolio of oral surgery, ... Bill joins the Collagen Matrix executive team ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
Breaking Medicine News(10 mins):